Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 43400 of 46697 entries
View as:
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 87
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 7
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 17
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 15
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Veena Ranganath, MD, MS | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Veena Ranganath, MD, MS.temp.org | 2025-07-14 |
| Veerle Ruijters | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Veerle Ruijters.temp.org | 2025-07-14 |
| Veerle Snijders | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Veerle Snijders.temp.org | 2025-07-14 |
| Vega Therapeutics, Inc | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vega Therapeutics, Inc.temp.org | 2025-07-14 |
| VegaVect, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | VegaVect, Inc..temp.org | 2025-07-14 |
| Vegenat, S.A. | - | 5 | 0.0% | 0 | 0 | 0.0% | - | Vegenat, S.A..temp.org | 2025-07-14 |
| Vejle Hospital | - | 87 | 0.0% | 0 | 0 | 0.0% | - | Vejle Hospital.temp.org | 2025-07-14 |
| Vejlefjord Rehabilitation | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vejlefjord Rehabilitation.temp.org | 2025-07-14 |
| Vektor Medical | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Vektor Medical.temp.org | 2025-07-14 |
| Vela Diagnostics | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vela Diagnostics.temp.org | 2025-07-14 |
| Velammal Medical College Hospital and Research Institute | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Velammal Medical College Hospital and Research Institute.temp.org | 2025-07-14 |
| Velano Vascular, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Velano Vascular, Inc..temp.org | 2025-07-14 |
| Velicept Therapeutics, Inc. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Velicept Therapeutics, Inc..temp.org | 2025-07-14 |
| Velico Medical | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Velico Medical.temp.org | 2025-07-14 |
| Velindre NHS Trust | - | 7 | 0.0% | 0 | 0 | 0.0% | - | Velindre NHS Trust.temp.org | 2025-07-14 |
| Veloce BioPharma LLC | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Veloce BioPharma LLC.temp.org | 2025-07-14 |
| Velomedix, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Velomedix, Inc..temp.org | 2025-07-14 |
| VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | - | 2 | 0.0% | 0 | 0 | 0.0% | - | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).temp.org | 2025-07-14 |
| Veloxis Pharmaceuticals | - | 17 | 0.0% | 0 | 0 | 0.0% | - | Veloxis Pharmaceuticals.temp.org | 2025-07-14 |
| Vemico Ltd. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vemico Ltd..temp.org | 2025-07-14 |
| Vena Vitals | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Vena Vitals.temp.org | 2025-07-14 |
| Venatorx Pharmaceuticals, Inc. | - | 15 | 0.0% | 0 | 0 | 0.0% | - | Venatorx Pharmaceuticals, Inc..temp.org | 2025-07-14 |
| Venaxis, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Venaxis, Inc..temp.org | 2025-07-14 |
| Venclose, Inc. | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Venclose, Inc..temp.org | 2025-07-14 |
| Venenklinik Bellevue | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Venenklinik Bellevue.temp.org | 2025-07-14 |